These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4591152)

  • 21. Efficacy of a new sustained release procainamide preparation: evaluation with 24-hour Holter monitoring.
    Garcia JR; Godley ML; Freedman RJ
    J La State Med Soc; 1982; 134(1):8-9. PubMed ID: 7086265
    [No Abstract]   [Full Text] [Related]  

  • 22. The assessment of an antiarrhythmic agent, sustained-release procainamide, with the aid of Holter monitoring.
    Bauer GE; Mitchell AS; Bates F; Hellestrand K
    Med J Aust; 1977 Nov; 2(22):733-5. PubMed ID: 347229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H; Skomedal T; Stafsnes H; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):257-62. PubMed ID: 805020
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 25. Absorption kinetics of procainamide in humans.
    Manion CV; Lalka D; Baer DT; Meyer MB
    J Pharm Sci; 1977 Jul; 66(7):981-4. PubMed ID: 886461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacokinetic comparison of two sustained-release oral procainamide preparations.
    Hore P; Bones P; Rollinson T; Ikram H
    Br J Clin Pharmacol; 1979 Sep; 8(3):267-71. PubMed ID: 497093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of the acetylation phenotype and the therapeutic effect of procainamide.
    Schröder P; Klitgaard NA; Simonsen E
    Eur J Clin Pharmacol; 1979 Feb; 15(1):63-8. PubMed ID: 84761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Dose intervals for procainamide.
    Reidenberg MM
    Lancet; 1975 Jun; 1(7922):1429-30. PubMed ID: 49596
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmias.
    Hilleman DE; Patterson AJ; Mohiuddin SM; Ortmeier BG; Destache CJ
    Drug Intell Clin Pharm; 1988; 22(7-8):554-8. PubMed ID: 2458219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular ectopy.
    Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
    J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of a sustained release procainamide preparation.
    Flanagan AD
    Angiology; 1982 Feb; 33(2):71-7. PubMed ID: 7039427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 34. Procaineamide blood levels after administration of a sustained-release preparation.
    Cunningham E; Sloman G
    Med J Aust; 1977 Mar; 1(11):370-2. PubMed ID: 870815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets.
    Koup JR; Abel RB; Smithers JA; Eldon MA; de Vries TM
    Ther Drug Monit; 1998 Feb; 20(1):73-7. PubMed ID: 9485559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of slow-release procainamide.
    Tilstone WJ; Lawson DH; Campbell W; Hutton I; Lawrie TD
    Eur J Clin Pharmacol; 1978 Dec; 14(4):261-5. PubMed ID: 729620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG; Davis LE; Davis CA
    J Vet Pharmacol Ther; 1986 Dec; 9(4):359-69. PubMed ID: 3806778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arrhythmia prophylaxis with procanamide: inadequate dosage?].
    Collste P; Karlsson E; Norlander B; Sievers J; Sjöqvist F
    Lakartidningen; 1972 Jun; 69():Suppl 2:47-50. PubMed ID: 4645697
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Fluorometric or gas-liquid chromatographic determination of procainamide?
    Frislid K; Bredesen JE; Lunde PK
    Clin Chem; 1975 Jul; 21(8):1180-2. PubMed ID: 1137928
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.